Work

pH-Responsive Mesoporous Silica Nanoparticles Functionalized with Aptamers for Targeted siRNA Delivery in Triple-Negative Breast Cancer Therapy

Year: 2025
Type: article
Abstract: Triple-negative breast cancer (TNBC) remains a recalcitrant malignancy due to its lack of hormone receptors and HER2 overexpression, limiting targeted therapy options. Small interfering RNA (siRNA)-based therapy holds promise for TNBC by silencing oncogenes, but its clinical translation is hindered by poor stability, low cellular uptake, and off-target effects. Herein, we developed a pH-responsive mesoporous silica nanoparticle (MSN) system functionalized with AS1411 aptamers for targeted siRNA delivery to TNBC cells. The MSNs were engineered with a pH-sensitive poly(β-amino ester) (PBAE) coating to facilitate endosomal escape and surface-conjugated with AS1411, which binds to nucleolin overexpressed on TNBC cell membranes. The siRNA targeting MCL-1 (a prosurvival oncogene) was loaded into the MSN pores via electrostatic interaction. In vitro studies showed that the aptamer-functionalized MSNs (Apt-MSNs) exhibited 3.2-fold higher cellular uptake in MDA-MB-231 TNBC cells than non-targeted MSNs, leading to 82.3% MCL-1 silencing and 67.5% cell apoptosis. In vivo, Apt-MSN/siMCL-1 significantly inhibited tumor growth in TNBC xenograft mice (tumor volume reduction of 71.2% vs. saline control) and reduced systemic toxicity, as evidenced by normal liver/kidney function and minimal organ damage. This work demonstrates the potential of aptamer-functionalized, pH-responsive MSNs as a targeted nanoplatform for siRNA delivery in TNBC therapy, highlighting the convergence of nanomaterial engineering and biomedicine for precision cancer treatment.
Language: English
Open Access status: diamond
OpenAlex ID: W7223427960
FWCI: 0.201
Cites: 7
Cited by: 1
Related to: 10